CN Patent

CN110013468B — 一种azd9291氘代衍生物药物制剂

Assigned to Deuracor Therapeutic Inc · Expires 2022-02-18 · 4y expired

What this patent protects

本发明提供一种AZD9291氘代衍生物药物制剂及其制备方法，该药物制剂包括AZD9291氘代衍生物或其药学上可接受的盐以及稀释剂，其中AZD9291氘代衍生物或其药学上可接受的盐的D 90 为20‑280μm。本发明得到的AZD9291氘代衍生物药物制剂溶出度高，稳定性好，适合工业化生产。

USPTO Abstract

本发明提供一种AZD9291氘代衍生物药物制剂及其制备方法，该药物制剂包括AZD9291氘代衍生物或其药学上可接受的盐以及稀释剂，其中AZD9291氘代衍生物或其药学上可接受的盐的D 90 为20‑280μm。本发明得到的AZD9291氘代衍生物药物制剂溶出度高，稳定性好，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN110013468B
Jurisdiction
CN
Classification
—
Expires
2022-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Deuracor Therapeutic Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.